Cognitive Behavioral Therapy for Insomnia
(CBTBI Trial)
Trial Summary
What is the purpose of this trial?
The objective of the study is to conduct a randomized controlled trial of Cognitive Behavioral Therapy for Insomnia (CBT-I) in a sample of active-duty sailors with a history of traumatic brain injury (TBI). The investigators will test the impact of CBT-I on insomnia symptoms as well as post-concussive symptoms, psychological symptoms, and neurocognitive functioning in comparison to treatment as usual. The investigators will also compare the effectiveness of traditional in-person CBT-I and CBT-I delivered via a clinician-supervised digital health platform, Clinician Operated Assistive Sleep Technology (COAST) in comparison to treatment as usual on symptoms of insomnia, post-concussive symptoms, neurocognitive functioning, and psychological health. Participants will be assessed at baseline, post-treatment, and 3 months later.
Will I have to stop taking my current medications?
You can continue taking your current psychotropic and hypnotic medications if you have been on the same dose for at least 8 weeks and there are no expected changes during the trial. The study will track any medication changes, but you don't need to stop taking them.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Insomnia (CBT-I)?
Is Cognitive Behavioral Therapy for Insomnia (CBT-I) safe for humans?
How is CBT-I treatment different from other treatments for insomnia?
CBT-I (Cognitive Behavioral Therapy for Insomnia) is unique because it is a non-drug treatment that focuses on changing sleep habits and behaviors, making it the first-line treatment for insomnia, even when it occurs alongside other health issues. Unlike medications, it addresses the root causes of insomnia and can be effective in a single session or over a longer period, depending on the individual's needs.16101112
Eligibility Criteria
This trial is for active-duty sailors who have experienced a traumatic brain injury (TBI) and are struggling with insomnia. Participants should be currently serving, have a history of TBI, and suffer from sleep problems. Details on specific inclusion or exclusion criteria were not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Behavioral Therapy for Insomnia (CBT-I) either in-person or via the COAST platform for 6 weeks
Post-treatment Assessment
Participants are assessed within 10 days after the treatment phase to evaluate insomnia, post-concussive symptoms, and psychological health
Follow-up
Participants are monitored for safety and effectiveness 3 months after treatment
Treatment Details
Interventions
- Cognitive Behavioral Therapy for Insomnia (CBT-I)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Noctem, LLC
Lead Sponsor
Naval Health Research Center
Collaborator
United States Naval Medical Center, San Diego
Collaborator